WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed May 16, 2023
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2023-05-15$0.46/sh+6,401$2,938→ 227,426 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.